×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 ... [117]
复旦大学上海医学院 [45]
山东大学 [12]
西安交通大学 [10]
中南大学 [8]
吉林大学白求恩第一医... [7]
更多...
内容类型
期刊论文 [181]
会议论文 [50]
发表日期
2023 [1]
2022 [1]
2021 [1]
2020 [2]
2019 [27]
2018 [23]
更多...
学科主题
Energy & F... [1]
材料科学与物理化学 [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共231条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Results of the phase IIa study to evaluate the efficacy and safety of rezivertinib (BPI-7711) for the first-line treatment of locally advanced or metastatic EGFR mutation from a phase I
期刊论文
BMC MEDICINE, 2023, 卷号: 21, 期号: 1
作者:
Yuankai Shi
;
Jianying Zhou
;
Yanqiu Zhao
;
Bo Zhu
;
Liangming Zhang
收藏
  |  
浏览/下载:0/0
  |  
提交时间:2024/05/07
Characterizing the Microscopic Anisotropic Permeabilities of Tight Oil Reservoirs Impacted by Heterogeneous Minerals
期刊论文
ENERGIES, 18, 2022, 卷号: 15, 页码: 6552
作者:
Wang, Ziqiang
;
Ge, Hongkui
;
Wei, Yun
;
Wang, Yi
;
Jia, Kerui
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2022/10/23
oil
two-dimensional permeability
flow anisotropy
Efficacy and Safety of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody (SCT400) Combined with CHOP in Patients with Treatment-Naive Diffuse Large B-Cell Lymphoma: A Multicenter, Randomized, Single-Blind, Parallel Active-Controlled, Phase III Study
期刊论文
BLOOD, 2021, 卷号: 138
作者:
Shi, Yuankai
;
Zhang, Qing Yuan
;
Hong, Xiaonan
;
Wang, Zhen
;
Gao, Yuhuan
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2022/12/23
Safety, Clinical Activity, and Pharmacokinetics of Al flutinib (AST2818) in Patients With Advanced NSCLC With EGFR T790M Mutation
期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2020, 卷号: 15, 期号: 6, 页码: 1015-1026
作者:
Shi, Yuankai
;
Zhang, Shucai
;
Hu, Xingsheng
;
Feng, Jifeng
;
Ma, Zhiyong
收藏
  |  
浏览/下载:38/0
  |  
提交时间:2020/12/24
Alflutinib
NSCLC
EGFR T790M mutation
Efficacy
Safety
Forecasting Method of Stock Market Volatility in Time Series Data Based on Mixed Model of ARIMA and XGBoost
期刊论文
CHINA COMMUNICATIONS, 2020, 卷号: 17, 期号: 3, 页码: 205-221
作者:
Wang, Yan
;
Guo, Yuankai
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2020/06/16
hybrid model
discrete wavelet transform
ARIMA
XGBoost
grid search
stock price forecast
Rh(i)-Catalyzed intramolecular [2+2+1] cycloaddition of diynes with the N-terminal of the diazo group
期刊论文
ORGANIC CHEMISTRY FRONTIERS, 2019, 卷号: 6, 期号: 14, 页码: 2329-2333
作者:
Wang, Bo
;
Wang, Yuankai
;
Wang, Zixuan
;
Wang, Jianbo
收藏
  |  
浏览/下载:38/0
  |  
提交时间:2019/12/02
The role of structural order and stiffness in the simultaneous enhancement of optical contrast and thermal stability in phase change materials
期刊论文
JOURNAL OF MATERIALS CHEMISTRY C, 2019, 卷号: 7, 期号: 14
作者:
Li, Qian
;
Xu, Kaicheng
;
Wang, Xiaoyi
;
Huang, Haihua
;
Ma, Liang
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2019/12/05
Primary breast diffuse large B-cell lymphoma in the rituximab era: therapeutic strategies and patterns of failure (vol 109, pg 3943, 2018)
期刊论文
CANCER SCIENCE, 2019, 卷号: 110, 期号: 4
作者:
Xiao, Xiubin
;
Bao, Huizheng
;
Wang, Ningju
;
Ren, Hanyun
;
Cen, Xinan
收藏
  |  
浏览/下载:59/0
  |  
提交时间:2019/12/05
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial
期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2019, 卷号: 14, 期号: 5
作者:
Wu, Yi-Long
;
Lu, Shun
;
Cheng, Ying
;
Zhou, Caicun
;
Wang, Jie
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2019/12/05
Chinese population
Nivolumab
NSCLC
Phase III clinical study
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trial
期刊论文
CANCER COMMUNICATIONS, 2019, 卷号: 39
作者:
Shi, Yuankai
;
Li, Jin
;
Xu, Jianming
;
Sun, Yan
;
Wang, Liwei
收藏
  |  
浏览/下载:113/0
  |  
提交时间:2019/12/05
CMAB009
Cetuximab
Irinotecan
Second-line
mCRC
EGFR
KRAS
Immunogenicity
Fluoropyrimidine
Oxaliplatin failure
©版权所有 ©2017 CSpace - Powered by
CSpace